0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Innovative Small Molecule Targeted Drugs Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-25G14716
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Innovative Small Molecule Targeted Drugs Market Research Report 2023
BUY CHAPTERS

Global Innovative Small Molecule Targeted Drugs Market Research Report 2025

Code: QYRE-Auto-25G14716
Report
May 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Innovative Small Molecule Targeted Drugs Market

The global market for Innovative Small Molecule Targeted Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Innovative Small Molecule Targeted Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Innovative Small Molecule Targeted Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Innovative Small Molecule Targeted Drugs include Roche, Pfizer, Genetech, Novartis, Bayer, Abbive, Jiangsu Hengrui Pharmaceuticals, Jiangsu Chia Tai-Tianqing Pharmaceutical, QILU Pharmaceutical, Betta Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Innovative Small Molecule Targeted Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Innovative Small Molecule Targeted Drugs.
The Innovative Small Molecule Targeted Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Innovative Small Molecule Targeted Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Innovative Small Molecule Targeted Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Innovative Small Molecule Targeted Drugs Market Report

Report Metric Details
Report Name Innovative Small Molecule Targeted Drugs Market
Segment by Type
Segment by Application
  • Hospital
  • Pharmacy
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Pfizer, Genetech, Novartis, Bayer, Abbive, Jiangsu Hengrui Pharmaceuticals, Jiangsu Chia Tai-Tianqing Pharmaceutical, QILU Pharmaceutical, Betta Pharmaceuticals, Shanghai Junshi Biosciences, Shanghai Allist Pharmaceuticals, Shenzhen Chipscreen Biosciences, Innovent Biologics, Inc., Hinova Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Innovative Small Molecule Targeted Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Innovative Small Molecule Targeted Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Innovative Small Molecule Targeted Drugs Market report?

Ans: The main players in the Innovative Small Molecule Targeted Drugs Market are Roche, Pfizer, Genetech, Novartis, Bayer, Abbive, Jiangsu Hengrui Pharmaceuticals, Jiangsu Chia Tai-Tianqing Pharmaceutical, QILU Pharmaceutical, Betta Pharmaceuticals, Shanghai Junshi Biosciences, Shanghai Allist Pharmaceuticals, Shenzhen Chipscreen Biosciences, Innovent Biologics, Inc., Hinova Pharmaceuticals

What are the Application segmentation covered in the Innovative Small Molecule Targeted Drugs Market report?

Ans: The Applications covered in the Innovative Small Molecule Targeted Drugs Market report are Hospital, Pharmacy

What are the Type segmentation covered in the Innovative Small Molecule Targeted Drugs Market report?

Ans: The Types covered in the Innovative Small Molecule Targeted Drugs Market report are Kinase Inhibitors, Epigenetic Inhibitors, Proteasome Inhibitor

Recommended Reports

Targeted Drug Therapy

Cancer Therapeutics

Molecular & Novel Drugs

1 Innovative Small Molecule Targeted Drugs Market Overview
1.1 Product Definition
1.2 Innovative Small Molecule Targeted Drugs by Type
1.2.1 Global Innovative Small Molecule Targeted Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Kinase Inhibitors
1.2.3 Epigenetic Inhibitors
1.2.4 Proteasome Inhibitor
1.3 Innovative Small Molecule Targeted Drugs by Application
1.3.1 Global Innovative Small Molecule Targeted Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Innovative Small Molecule Targeted Drugs Market Size Estimates and Forecasts
1.4.1 Global Innovative Small Molecule Targeted Drugs Revenue 2020-2031
1.4.2 Global Innovative Small Molecule Targeted Drugs Sales 2020-2031
1.4.3 Global Innovative Small Molecule Targeted Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Innovative Small Molecule Targeted Drugs Market Competition by Manufacturers
2.1 Global Innovative Small Molecule Targeted Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Innovative Small Molecule Targeted Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Innovative Small Molecule Targeted Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Innovative Small Molecule Targeted Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Innovative Small Molecule Targeted Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Innovative Small Molecule Targeted Drugs, Product Type & Application
2.7 Global Key Manufacturers of Innovative Small Molecule Targeted Drugs, Date of Enter into This Industry
2.8 Global Innovative Small Molecule Targeted Drugs Market Competitive Situation and Trends
2.8.1 Global Innovative Small Molecule Targeted Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Innovative Small Molecule Targeted Drugs Players Market Share by Revenue
2.8.3 Global Innovative Small Molecule Targeted Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Innovative Small Molecule Targeted Drugs Market Scenario by Region
3.1 Global Innovative Small Molecule Targeted Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Innovative Small Molecule Targeted Drugs Sales by Region: 2020-2031
3.2.1 Global Innovative Small Molecule Targeted Drugs Sales by Region: 2020-2025
3.2.2 Global Innovative Small Molecule Targeted Drugs Sales by Region: 2026-2031
3.3 Global Innovative Small Molecule Targeted Drugs Revenue by Region: 2020-2031
3.3.1 Global Innovative Small Molecule Targeted Drugs Revenue by Region: 2020-2025
3.3.2 Global Innovative Small Molecule Targeted Drugs Revenue by Region: 2026-2031
3.4 North America Innovative Small Molecule Targeted Drugs Market Facts & Figures by Country
3.4.1 North America Innovative Small Molecule Targeted Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Innovative Small Molecule Targeted Drugs Sales by Country (2020-2031)
3.4.3 North America Innovative Small Molecule Targeted Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Innovative Small Molecule Targeted Drugs Market Facts & Figures by Country
3.5.1 Europe Innovative Small Molecule Targeted Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Innovative Small Molecule Targeted Drugs Sales by Country (2020-2031)
3.5.3 Europe Innovative Small Molecule Targeted Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Innovative Small Molecule Targeted Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Innovative Small Molecule Targeted Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Innovative Small Molecule Targeted Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Innovative Small Molecule Targeted Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Innovative Small Molecule Targeted Drugs Market Facts & Figures by Country
3.7.1 Latin America Innovative Small Molecule Targeted Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Innovative Small Molecule Targeted Drugs Sales by Country (2020-2031)
3.7.3 Latin America Innovative Small Molecule Targeted Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Innovative Small Molecule Targeted Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Innovative Small Molecule Targeted Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Innovative Small Molecule Targeted Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Innovative Small Molecule Targeted Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Innovative Small Molecule Targeted Drugs Sales by Type (2020-2031)
4.1.1 Global Innovative Small Molecule Targeted Drugs Sales by Type (2020-2025)
4.1.2 Global Innovative Small Molecule Targeted Drugs Sales by Type (2026-2031)
4.1.3 Global Innovative Small Molecule Targeted Drugs Sales Market Share by Type (2020-2031)
4.2 Global Innovative Small Molecule Targeted Drugs Revenue by Type (2020-2031)
4.2.1 Global Innovative Small Molecule Targeted Drugs Revenue by Type (2020-2025)
4.2.2 Global Innovative Small Molecule Targeted Drugs Revenue by Type (2026-2031)
4.2.3 Global Innovative Small Molecule Targeted Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Innovative Small Molecule Targeted Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Innovative Small Molecule Targeted Drugs Sales by Application (2020-2031)
5.1.1 Global Innovative Small Molecule Targeted Drugs Sales by Application (2020-2025)
5.1.2 Global Innovative Small Molecule Targeted Drugs Sales by Application (2026-2031)
5.1.3 Global Innovative Small Molecule Targeted Drugs Sales Market Share by Application (2020-2031)
5.2 Global Innovative Small Molecule Targeted Drugs Revenue by Application (2020-2031)
5.2.1 Global Innovative Small Molecule Targeted Drugs Revenue by Application (2020-2025)
5.2.2 Global Innovative Small Molecule Targeted Drugs Revenue by Application (2026-2031)
5.2.3 Global Innovative Small Molecule Targeted Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Innovative Small Molecule Targeted Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Innovative Small Molecule Targeted Drugs Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Innovative Small Molecule Targeted Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Genetech
6.3.1 Genetech Company Information
6.3.2 Genetech Description and Business Overview
6.3.3 Genetech Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Genetech Innovative Small Molecule Targeted Drugs Product Portfolio
6.3.5 Genetech Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis Innovative Small Molecule Targeted Drugs Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Company Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bayer Innovative Small Molecule Targeted Drugs Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Abbive
6.6.1 Abbive Company Information
6.6.2 Abbive Description and Business Overview
6.6.3 Abbive Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Abbive Innovative Small Molecule Targeted Drugs Product Portfolio
6.6.5 Abbive Recent Developments/Updates
6.7 Jiangsu Hengrui Pharmaceuticals
6.7.1 Jiangsu Hengrui Pharmaceuticals Company Information
6.7.2 Jiangsu Hengrui Pharmaceuticals Description and Business Overview
6.7.3 Jiangsu Hengrui Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Jiangsu Hengrui Pharmaceuticals Innovative Small Molecule Targeted Drugs Product Portfolio
6.7.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
6.8 Jiangsu Chia Tai-Tianqing Pharmaceutical
6.8.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Company Information
6.8.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Description and Business Overview
6.8.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Innovative Small Molecule Targeted Drugs Product Portfolio
6.8.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
6.9 QILU Pharmaceutical
6.9.1 QILU Pharmaceutical Company Information
6.9.2 QILU Pharmaceutical Description and Business Overview
6.9.3 QILU Pharmaceutical Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 QILU Pharmaceutical Innovative Small Molecule Targeted Drugs Product Portfolio
6.9.5 QILU Pharmaceutical Recent Developments/Updates
6.10 Betta Pharmaceuticals
6.10.1 Betta Pharmaceuticals Company Information
6.10.2 Betta Pharmaceuticals Description and Business Overview
6.10.3 Betta Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Betta Pharmaceuticals Innovative Small Molecule Targeted Drugs Product Portfolio
6.10.5 Betta Pharmaceuticals Recent Developments/Updates
6.11 Shanghai Junshi Biosciences
6.11.1 Shanghai Junshi Biosciences Company Information
6.11.2 Shanghai Junshi Biosciences Description and Business Overview
6.11.3 Shanghai Junshi Biosciences Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Shanghai Junshi Biosciences Innovative Small Molecule Targeted Drugs Product Portfolio
6.11.5 Shanghai Junshi Biosciences Recent Developments/Updates
6.12 Shanghai Allist Pharmaceuticals
6.12.1 Shanghai Allist Pharmaceuticals Company Information
6.12.2 Shanghai Allist Pharmaceuticals Description and Business Overview
6.12.3 Shanghai Allist Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Shanghai Allist Pharmaceuticals Innovative Small Molecule Targeted Drugs Product Portfolio
6.12.5 Shanghai Allist Pharmaceuticals Recent Developments/Updates
6.13 Shenzhen Chipscreen Biosciences
6.13.1 Shenzhen Chipscreen Biosciences Company Information
6.13.2 Shenzhen Chipscreen Biosciences Description and Business Overview
6.13.3 Shenzhen Chipscreen Biosciences Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Shenzhen Chipscreen Biosciences Innovative Small Molecule Targeted Drugs Product Portfolio
6.13.5 Shenzhen Chipscreen Biosciences Recent Developments/Updates
6.14 Innovent Biologics, Inc.
6.14.1 Innovent Biologics, Inc. Company Information
6.14.2 Innovent Biologics, Inc. Description and Business Overview
6.14.3 Innovent Biologics, Inc. Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Innovent Biologics, Inc. Innovative Small Molecule Targeted Drugs Product Portfolio
6.14.5 Innovent Biologics, Inc. Recent Developments/Updates
6.15 Hinova Pharmaceuticals
6.15.1 Hinova Pharmaceuticals Company Information
6.15.2 Hinova Pharmaceuticals Description and Business Overview
6.15.3 Hinova Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Hinova Pharmaceuticals Innovative Small Molecule Targeted Drugs Product Portfolio
6.15.5 Hinova Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Innovative Small Molecule Targeted Drugs Industry Chain Analysis
7.2 Innovative Small Molecule Targeted Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Innovative Small Molecule Targeted Drugs Production Mode & Process Analysis
7.4 Innovative Small Molecule Targeted Drugs Sales and Marketing
7.4.1 Innovative Small Molecule Targeted Drugs Sales Channels
7.4.2 Innovative Small Molecule Targeted Drugs Distributors
7.5 Innovative Small Molecule Targeted Drugs Customer Analysis
8 Innovative Small Molecule Targeted Drugs Market Dynamics
8.1 Innovative Small Molecule Targeted Drugs Industry Trends
8.2 Innovative Small Molecule Targeted Drugs Market Drivers
8.3 Innovative Small Molecule Targeted Drugs Market Challenges
8.4 Innovative Small Molecule Targeted Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Innovative Small Molecule Targeted Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Innovative Small Molecule Targeted Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Innovative Small Molecule Targeted Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Innovative Small Molecule Targeted Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Innovative Small Molecule Targeted Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Innovative Small Molecule Targeted Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Innovative Small Molecule Targeted Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Innovative Small Molecule Targeted Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Innovative Small Molecule Targeted Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Innovative Small Molecule Targeted Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Innovative Small Molecule Targeted Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Innovative Small Molecule Targeted Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Innovative Small Molecule Targeted Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Innovative Small Molecule Targeted Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Innovative Small Molecule Targeted Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Innovative Small Molecule Targeted Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Innovative Small Molecule Targeted Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Innovative Small Molecule Targeted Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Innovative Small Molecule Targeted Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Innovative Small Molecule Targeted Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Innovative Small Molecule Targeted Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Innovative Small Molecule Targeted Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Innovative Small Molecule Targeted Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Innovative Small Molecule Targeted Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Innovative Small Molecule Targeted Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Innovative Small Molecule Targeted Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Innovative Small Molecule Targeted Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Innovative Small Molecule Targeted Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Innovative Small Molecule Targeted Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Innovative Small Molecule Targeted Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Innovative Small Molecule Targeted Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Innovative Small Molecule Targeted Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Innovative Small Molecule Targeted Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Innovative Small Molecule Targeted Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Innovative Small Molecule Targeted Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Innovative Small Molecule Targeted Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Innovative Small Molecule Targeted Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Innovative Small Molecule Targeted Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Innovative Small Molecule Targeted Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Innovative Small Molecule Targeted Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Innovative Small Molecule Targeted Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Innovative Small Molecule Targeted Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Innovative Small Molecule Targeted Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Innovative Small Molecule Targeted Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Innovative Small Molecule Targeted Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Innovative Small Molecule Targeted Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Innovative Small Molecule Targeted Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Innovative Small Molecule Targeted Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Innovative Small Molecule Targeted Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Innovative Small Molecule Targeted Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Innovative Small Molecule Targeted Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Innovative Small Molecule Targeted Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Innovative Small Molecule Targeted Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Innovative Small Molecule Targeted Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Innovative Small Molecule Targeted Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Innovative Small Molecule Targeted Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Innovative Small Molecule Targeted Drugs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Innovative Small Molecule Targeted Drugs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Innovative Small Molecule Targeted Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Innovative Small Molecule Targeted Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Innovative Small Molecule Targeted Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Innovative Small Molecule Targeted Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Innovative Small Molecule Targeted Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Innovative Small Molecule Targeted Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Innovative Small Molecule Targeted Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Innovative Small Molecule Targeted Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Innovative Small Molecule Targeted Drugs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Innovative Small Molecule Targeted Drugs Price (US$/Unit) by Application (2026-2031)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Roche Innovative Small Molecule Targeted Drugs Product
 Table 74. Roche Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Pfizer Innovative Small Molecule Targeted Drugs Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. Genetech Company Information
 Table 81. Genetech Description and Business Overview
 Table 82. Genetech Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Genetech Innovative Small Molecule Targeted Drugs Product
 Table 84. Genetech Recent Developments/Updates
 Table 85. Novartis Company Information
 Table 86. Novartis Description and Business Overview
 Table 87. Novartis Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Novartis Innovative Small Molecule Targeted Drugs Product
 Table 89. Novartis Recent Developments/Updates
 Table 90. Bayer Company Information
 Table 91. Bayer Description and Business Overview
 Table 92. Bayer Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Bayer Innovative Small Molecule Targeted Drugs Product
 Table 94. Bayer Recent Developments/Updates
 Table 95. Abbive Company Information
 Table 96. Abbive Description and Business Overview
 Table 97. Abbive Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Abbive Innovative Small Molecule Targeted Drugs Product
 Table 99. Abbive Recent Developments/Updates
 Table 100. Jiangsu Hengrui Pharmaceuticals Company Information
 Table 101. Jiangsu Hengrui Pharmaceuticals Description and Business Overview
 Table 102. Jiangsu Hengrui Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Jiangsu Hengrui Pharmaceuticals Innovative Small Molecule Targeted Drugs Product
 Table 104. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
 Table 105. Jiangsu Chia Tai-Tianqing Pharmaceutical Company Information
 Table 106. Jiangsu Chia Tai-Tianqing Pharmaceutical Description and Business Overview
 Table 107. Jiangsu Chia Tai-Tianqing Pharmaceutical Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Jiangsu Chia Tai-Tianqing Pharmaceutical Innovative Small Molecule Targeted Drugs Product
 Table 109. Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
 Table 110. QILU Pharmaceutical Company Information
 Table 111. QILU Pharmaceutical Description and Business Overview
 Table 112. QILU Pharmaceutical Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. QILU Pharmaceutical Innovative Small Molecule Targeted Drugs Product
 Table 114. QILU Pharmaceutical Recent Developments/Updates
 Table 115. Betta Pharmaceuticals Company Information
 Table 116. Betta Pharmaceuticals Description and Business Overview
 Table 117. Betta Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Betta Pharmaceuticals Innovative Small Molecule Targeted Drugs Product
 Table 119. Betta Pharmaceuticals Recent Developments/Updates
 Table 120. Shanghai Junshi Biosciences Company Information
 Table 121. Shanghai Junshi Biosciences Description and Business Overview
 Table 122. Shanghai Junshi Biosciences Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Shanghai Junshi Biosciences Innovative Small Molecule Targeted Drugs Product
 Table 124. Shanghai Junshi Biosciences Recent Developments/Updates
 Table 125. Shanghai Allist Pharmaceuticals Company Information
 Table 126. Shanghai Allist Pharmaceuticals Description and Business Overview
 Table 127. Shanghai Allist Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Shanghai Allist Pharmaceuticals Innovative Small Molecule Targeted Drugs Product
 Table 129. Shanghai Allist Pharmaceuticals Recent Developments/Updates
 Table 130. Shenzhen Chipscreen Biosciences Company Information
 Table 131. Shenzhen Chipscreen Biosciences Description and Business Overview
 Table 132. Shenzhen Chipscreen Biosciences Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Shenzhen Chipscreen Biosciences Innovative Small Molecule Targeted Drugs Product
 Table 134. Shenzhen Chipscreen Biosciences Recent Developments/Updates
 Table 135. Innovent Biologics, Inc. Company Information
 Table 136. Innovent Biologics, Inc. Description and Business Overview
 Table 137. Innovent Biologics, Inc. Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Innovent Biologics, Inc. Innovative Small Molecule Targeted Drugs Product
 Table 139. Innovent Biologics, Inc. Recent Developments/Updates
 Table 140. Hinova Pharmaceuticals Company Information
 Table 141. Hinova Pharmaceuticals Description and Business Overview
 Table 142. Hinova Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Hinova Pharmaceuticals Innovative Small Molecule Targeted Drugs Product
 Table 144. Hinova Pharmaceuticals Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Innovative Small Molecule Targeted Drugs Distributors List
 Table 148. Innovative Small Molecule Targeted Drugs Customers List
 Table 149. Innovative Small Molecule Targeted Drugs Market Trends
 Table 150. Innovative Small Molecule Targeted Drugs Market Drivers
 Table 151. Innovative Small Molecule Targeted Drugs Market Challenges
 Table 152. Innovative Small Molecule Targeted Drugs Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Innovative Small Molecule Targeted Drugs
 Figure 2. Global Innovative Small Molecule Targeted Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Innovative Small Molecule Targeted Drugs Market Share by Type: 2024 & 2031
 Figure 4. Kinase Inhibitors Product Picture
 Figure 5. Epigenetic Inhibitors Product Picture
 Figure 6. Proteasome Inhibitor Product Picture
 Figure 7. Global Innovative Small Molecule Targeted Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Innovative Small Molecule Targeted Drugs Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Pharmacy
 Figure 11. Global Innovative Small Molecule Targeted Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Innovative Small Molecule Targeted Drugs Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Innovative Small Molecule Targeted Drugs Sales (2020-2031) & (K Units)
 Figure 14. Global Innovative Small Molecule Targeted Drugs Average Price (US$/Unit) & (2020-2031)
 Figure 15. Innovative Small Molecule Targeted Drugs Report Years Considered
 Figure 16. Innovative Small Molecule Targeted Drugs Sales Share by Manufacturers in 2024
 Figure 17. Global Innovative Small Molecule Targeted Drugs Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Innovative Small Molecule Targeted Drugs Players: Market Share by Revenue in Innovative Small Molecule Targeted Drugs in 2024
 Figure 19. Innovative Small Molecule Targeted Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Innovative Small Molecule Targeted Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Innovative Small Molecule Targeted Drugs Sales Market Share by Country (2020-2031)
 Figure 22. North America Innovative Small Molecule Targeted Drugs Revenue Market Share by Country (2020-2031)
 Figure 23. United States Innovative Small Molecule Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Innovative Small Molecule Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Innovative Small Molecule Targeted Drugs Sales Market Share by Country (2020-2031)
 Figure 26. Europe Innovative Small Molecule Targeted Drugs Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Innovative Small Molecule Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Innovative Small Molecule Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Innovative Small Molecule Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Innovative Small Molecule Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Innovative Small Molecule Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Innovative Small Molecule Targeted Drugs Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Innovative Small Molecule Targeted Drugs Revenue Market Share by Region (2020-2031)
 Figure 34. China Innovative Small Molecule Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Innovative Small Molecule Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Innovative Small Molecule Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Innovative Small Molecule Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Innovative Small Molecule Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Innovative Small Molecule Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Innovative Small Molecule Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Innovative Small Molecule Targeted Drugs Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Innovative Small Molecule Targeted Drugs Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Innovative Small Molecule Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Innovative Small Molecule Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Innovative Small Molecule Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Innovative Small Molecule Targeted Drugs Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Innovative Small Molecule Targeted Drugs Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Innovative Small Molecule Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Innovative Small Molecule Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Innovative Small Molecule Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Innovative Small Molecule Targeted Drugs by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Innovative Small Molecule Targeted Drugs by Type (2020-2031)
 Figure 53. Global Innovative Small Molecule Targeted Drugs Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Innovative Small Molecule Targeted Drugs by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Innovative Small Molecule Targeted Drugs by Application (2020-2031)
 Figure 56. Global Innovative Small Molecule Targeted Drugs Price (US$/Unit) by Application (2020-2031)
 Figure 57. Innovative Small Molecule Targeted Drugs Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart